Allergen, Individual-Tree pollen Oak Quercus Alba T7

The Allergen, Individual-Tree Pollen Oak Quercus Alba T7 test detects sensitization to Oak (Quercus alba) pollen by measuring specific IgE antibodies in a patient blood sample. Performed from an at-home collection, this quantitative assay identifies whether the immune system has developed an allergic response to oak pollen and provides levels that help classify sensitization severity.

This test is particularly useful for people who experience seasonal nasal, ocular or respiratory allergy symptoms and for clinicians planning targeted management such as allergen avoidance strategies or selecting candidates for allergen immunotherapy. Results are suitable for use by UAE-based physicians and allergy specialists to guide personalised treatment decisions and monitor response over time.

• Quercus alba (Oak) pollen-specific IgE
• Specific IgE concentration (kU/L)
• Sensitization class/grade (e.g., Class 0–6)

• Recurrent seasonal sneezing, nasal congestion or itchy eyes during tree pollen seasons
• Worsening asthma or cough linked to outdoor exposure near trees
• Unclear allergy triggers despite general allergy testing
• Pre-evaluation before starting allergen immunotherapy
• When planning travel or relocation to areas with oak pollen exposure

• Identifies sensitization to Oak (Quercus alba) pollen with quantitative results
• Supports targeted avoidance measures and environmental control
• Guides selection and monitoring of allergen immunotherapy
• Convenient home sample collection compatible with Dubai healthcare providers
• Provides actionable data for specialist consultation and personalised treatment

• At‑home blood sample collection (finger‑prick or venous draw by a certified phlebotomist)
• No fasting required
• Inform provider if receiving allergen immunotherapy or biologic treatments (e.g., omalizumab)
• Provide Emirates ID and valid contact details for result delivery and clinical follow-up